ADORE: impAct of coviD On feRtility carE

Overview

About this study

The purpose of this study is to examine the experiences of women and their partner seeking reproductive endocrinology and infertility (REI) care during the COVID-19 outbreak.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Female patients or their partners with a REI procedure scheduled at Mayo Clinic within 6 months of 3/15/2020.

Exclusion Criteria:

  • Female patients or their partners who have not had an REI procedure scheduled at Mayo Clinic or within the 6 months of 3/15/2020.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Megan Allyse, Ph.D.

Closed for enrollment

Contact information:

Karen DSouza

(507) 255-9590

DSouza.Karen@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20503573

Mayo Clinic Footer